Zealand Pharma

Director's Dealing • Nov 10, 2016

---

author: "Tine T\u00f8nnesen"
date: 2016-11-10 10:56:00+00:00
processing_status: success_python-docx_mammoth

---

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Andrew Parker
2.	Reason for the notification
a)	Position/status	Senior Vice President, Chief Science Officer in Zealand Pharma A/S
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20 04 50 78
b)	LEI[1]	LE0116846
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Shares DK0060257814
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
d)	Aggregated information * Aggregated volume * Price	3,395 shares DKK 299,465.00
e)	Date of the transaction	2016-11-09
f)	Place of the transaction	Nasdaq Copenhagen A/S

1. ↑